Abeona Therapeutics logo

Abeona Therapeutics Share Price (NASDAQ: ABEO)

Market is closed - opens 7 PM, 28 Jul 2025

$6.54

-0.11

(-1.65%)

Last updated on 25 Jul 2025, 07:59 PM IST

Check the interactive Abeona Therapeutics Stock chart to analyse performance

Abeona Therapeutics stock performance

as on 25 Jul 2025, 07:59 PM

  • Today's Low: $6.37
    Today's High: $6.62

    Day's Volatility :3.78%

  • 52 Weeks Low: $3.93
    52 Weeks High: $7.32

    52 Weeks Volatility :46.3%

Abeona Therapeutics Stock Returns

PeriodAbeona Therapeutics Inc.Russel 2000Index (Russel 2000)
3 Months
24.58%
0.0%
0.0%
6 Months
25.75%
0.0%
0.0%
1 Year
30.69%
0.0%
0.0%
3 Years
70.46%
-2.0%
-2.0%

Abeona Therapeutics Key Stats

Check Abeona Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$6.65
Open
$6.61
Today's High
$6.62
Today's Low
$6.37
Market Capitalization
$343.3M
Today's Volume
$527.2K
52 Week High
$7.3236
52 Week Low
$3.9328
Revenue TTM
$0.0
EBITDA
$-67.6M
Earnings Per Share (EPS)
$-0.63
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-271.78%

Stock Returns calculator for Abeona Therapeutics Stock including INR - Dollar returns

The Abeona Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Abeona Therapeutics investment value today

Current value as on today

₹1,31,661

Returns

₹31,661

(+31.66%)

Returns from Abeona Therapeutics Stock

₹28,235 (+28.24%)

Dollar Returns*

₹3,425 (+3.43%)

Indian investors sentiment towards Abeona Therapeutics Stock

31%

Period: Jun 25, 2025 to Jul 25, 2025. Change in 30 Days versus previous period

Search interest for Abeona Therapeutics Stock from India on INDmoney has increased by 31% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Abeona Therapeutics

  • Suvretta Capital Management, LLC

    7.20%

  • Nantahala Capital Management, LLC

    6.86%

  • Adage Capital Partners Gp LLC

    5.26%

  • Western Standard LLC

    4.46%

  • Vanguard Group Inc

    3.95%

  • Vivo Capital, LLC

    3.60%

Analyst Recommendation on Abeona Therapeutics Stock

Rating
Trend

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Abeona Therapeutics(by analysts ranked 0 to 5 stars)

Abeona Therapeutics Share Price Target

What analysts predicted

Upside of 204.72%

Target:

$19.93

Current:

$6.54

Abeona Therapeutics Stock Insights

  • Price Movement

    In the last 1 month, ABEO stock has moved up by 13.0%
  • ABEO vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 82.2% return, outperforming this stock by 51.5%
  • ABEO vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 67.1% return, outperforming this stock by 0.5%

Abeona Therapeutics Technicals Summary

Sell

Neutral

Buy

Abeona Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Abeona Therapeutics Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Abeona Therapeutics Inc. logo
12.97%
25.75%
30.69%
70.46%
-91.23%
Alnylam Pharmaceuticals, Inc. logo
3.1%
18.56%
39.71%
131.11%
108.3%
Regeneron Pharmaceuticals, Inc. logo
8.36%
-17.55%
-47.66%
-3.98%
-11.43%
Beone Medicines Ltd logo
16.39%
31.5%
82.23%
66.77%
32.23%
Vertex Pharmaceuticals Incorporated logo
6.51%
6.4%
-4.64%
64.56%
66.17%

About Abeona Therapeutics

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
Organization
Abeona Therapeutics
Employees
136
CEO
Dr. Vishwas Seshadri M.B.A., Ph.D.
Industry
Health Technology

Key Management People of Abeona Therapeutics

NameTitle
Dr. Vishwas Seshadri M.B.A., Ph.D.
President, CEO & Director
Mr. Joseph Walter Vazzano CPA
Chief Financial Officer
Dr. Brendan M. O'Malley J.D., Ph.D.
Chief Legal Officer
Mr. Brian Kevany Ph.D.
Senior VP, CTO & CSO
Mr. Gregory Gin
Vice President of Investor Relations & Corporate Communications
Ms. Alison Hardgrove
Chief People Officer
Mr. Jon Voss
VP & Head of Quality
Dr. Madhav Vasanthavada M.B.A., Ph.D.
Senior VP, Chief Commercial Officer & Head of Business Development
Mr. Carl Denny
Senior Vice President of Regulatory Affairs
Ms. Megan Callan
Vice President & Head of Quality

Important FAQs about investing in ABEO Stock from India :

How to invest in Abeona Therapeutics Stock (ABEO) from India?

It is very easy for Indian residents to invest directly in Abeona Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Abeona Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Abeona Therapeutics or ABEO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Abeona Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Abeona Therapeutics shares which would translate to 0.132 fractional shares of Abeona Therapeutics as of today. Learn more about fractional investing.

Can Indians buy Abeona Therapeutics shares?

Yes, Indians can invest in the Abeona Therapeutics (ABEO) from India.

With INDmoney, you can buy Abeona Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Abeona Therapeutics at zero transaction cost.

How can I buy Abeona Therapeutics shares from India?

It is very easy to buy Abeona Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Abeona Therapeutics (ABEO) be purchased?

Yes, you can buy fractional shares of Abeona Therapeutics with INDmoney app.

What are the documents required to start investing in Abeona Therapeutics stocks?

To start investing in Abeona Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Abeona Therapeutics share price today?

Abeona Therapeutics share price today stands at $6.54, Open: $6.61 ; Previous Close: $6.65 ; High: $6.62 ; Low: $6.37 ; 52 Week High: $7.32 ; 52 Week Low: $3.93.

The stock opens at $6.61, after a closing price of $6.65. The stock reached a daily high of $6.62 and a low of $6.37, with a 52-week high of $7.32 and a 52-week low of $3.93.

What are today’s High and Low prices of Abeona Therapeutics Stock (ABEO)?

Today’s highest price of Abeona Therapeutics (ABEO) is $6.62.

Today’s lowest price of Abeona Therapeutics (ABEO) is $6.37.

What is the 52 Week High and Low Range of Abeona Therapeutics Stock (ABEO)?

  • 52 Week High

    $7.32

  • 52 Week Low

    $3.93

What are the historical returns of Abeona Therapeutics (ABEO)?

  • 1 Month Returns

    12.97%

  • 3 Months Returns

    25.75%

  • 1 Year Returns

    30.69%

  • 5 Years Returns

    -91.23%

What is today's market capitalisation of Abeona Therapeutics?

Today's market capitalisation of Abeona Therapeutics ABEO is 343.3M

Who is the Chief Executive Officer (CEO) of Abeona Therapeutics ?

Dr. Vishwas Seshadri M.B.A., Ph.D. is the current Chief Executive Officer (CEO) of Abeona Therapeutics.